Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 23, 2025

September 23, 2025

Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis

GlobeNewswire

September 23, 2025

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation

GlobeNewswire

September 23, 2025

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

GlobeNewswire

September 23, 2025

Altimmune to Participate in Two Upcoming Investor Conferences

GlobeNewswire

September 23, 2025

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22

GlobeNewswire

September 23, 2025

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA

GlobeNewswire

September 23, 2025

Microbix Assisting EMQN with Second Genetic-Test EQA Program

GlobeNewswire

September 23, 2025

Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award

GlobeNewswire

September 23, 2025

SEED Therapeutics Completes $30 Million Series A-3 Financing

GlobeNewswire

September 23, 2025

BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer

GlobeNewswire

September 23, 2025

Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway

GlobeNewswire

September 23, 2025

Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup

GlobeNewswire

September 23, 2025

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

GlobeNewswire

September 23, 2025

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“

GlobeNewswire

September 23, 2025

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

GlobeNewswire

September 23, 2025

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 202…

GlobeNewswire

September 23, 2025

NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor

GlobeNewswire

September 23, 2025

2025 InnoMatch Tech-Matching Fair Opens in Shanghai to Push Global Sci-Tech Cooperation

GlobeNewswire

September 23, 2025

Labviva Kicks Off Smart Lab of the Future Tour

GlobeNewswire

September 23, 2025

Santhera gibt die Finanzergebnisse für das erste Halbjahr 2025 bekannt und informiert über aktuelle Unternehmensentwicklungen

GlobeNewswire